Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001824293-23-000187
Filing Date
2024-01-02
Accepted
2023-12-29 17:57:45
Documents
4
Period of Report
2024-01-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A specialmeetingproxy_dec2023.htm DEF 14A 178000
2 GRAPHIC image_0.jpg GRAPHIC 19695
3 GRAPHIC screenshot2023-12x18185922a.jpg GRAPHIC 108774
4 GRAPHIC screenshot2023-12x18190025a.jpg GRAPHIC 128657
  Complete submission text file 0001824293-23-000187.txt   533741
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40034 | Film No.: 231528901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)